Dan Galles
InvestorPartner at Allumia Ventures Β· Director of Issuer at Wildflower Health
San Francisco Bay Area
Find your path to Dan
416 people in our graph share verified history with Dan β schools, employers, funds. One of them is your warm intro.
About
Dan Galles is a Partner at Allumia Ventures, which he joined in 2015, focusing on healthcare information technology, healthcare services, and medical devices. He has more than 20 years of experience backing early- and growth-stage healthcare companies, previously serving as a partner at HLM Venture Partners, an associate at J.H. Whitney and Co., and an analyst in healthcare investment banking at Alex. Brown & Sons. He earned an MBA from Northwestern's Kellogg School and a BS in Economics from The Wharton School.
ContactΒ· self-published, not guessed
Invests in
Digital HealthHealthtechMedical Devices
Director of Issuer at Wildflower Health
Intro paths
In turn, Dan can intro founders to Wildflower Health's investors below.
Wildflower Health's investors Β· 4
Co-founders at Wildflower Health

Experience
- Allumia Ventures (fka Providence Ventures)Partnercurrent2015 β presentSan Francisco Bay Area
- AVIABoard Membercurrent2023 β presentChicago, Illinois, United States
- TailorMedBoard Membercurrent2023 β presentNew York, New York, United States
- BloodbuyBoard Membercurrent2018 β presentDallas, Texas, United States
- Arrive HealthBoard Member2021 β 2026Denver, Colorado, United States
- Kyruus HealthBoard Member2022 β 2025
- XealthBoard Member2017 β 2025Seattle, Washington, United States
- Omada HealthBoard Observer2018 β 2025San Francisco, California, United States
- Wildflower HealthBoard Member2024 β 2025San Francisco Bay Area
- Clearsense, LLCBoard Member2018 β 2022Jacksonville, Florida, United States
- Gauss SurgicalBoard Member2016 β 2021Los Altos, CA
- Twistle by Health CatalystBoard Observer2020 β 2021Albuquerque, New Mexico, United States
- HLM Venture PartnersPartner2001 β 2015San Francisco Bay Area
- J.H. Whitney & Co.Associate1997 β 1999
- Alex Brown & SonsAnalyst1995 β 1997
Skills & more
+11 more
MergersMergers & AcquisitionsPharmaceutical IndustryDeal SourcingManagement ConsultingPrivate EquityStart-upsStrategic PlanningTechnology TransferVenture FinancingStrategyFrom Dan's professional profile.
Investments
Board seats
Arrive HealthAVIAGauss SurgicalKyruusOmadaPraiaTailorMedTwistleWildflowerXealth
Investor
LyraOne MedicalPress Ganey
Per the firm's website.
Colleagues at Allumia Ventures
Frequently asked questions
- Who is Dan Galles?
- Dan Galles is a Partner at Allumia Ventures, which he joined in 2015, focusing on healthcare information technology, healthcare services, and medical devices. He has more than 20 years of experience backing early- and growth-stage healthcare companies, previously serving as a partner at HLM Venture Partners, an associate at J.H. Whitney and Co., and an analyst in healthcare investment banking at Alex. Brown & Sons. He earned an MBA from Northwestern's Kellogg School and a BS in Economics from The Wharton School.
- Where does Dan Galles work?
- Dan Galles is Partner at Allumia Ventures and Director of Issuer at Wildflower Health.
- What does Dan Galles invest in?
- Dan Galles invests in Digital Health, Healthtech, Medical Devices.
- What boards does Dan Galles sit on?
- Dan Galles holds tracked board seats at Arrive Health, AVIA, Gauss Surgical, Kyruus, Omada, Praia, TailorMed, Twistle, Wildflower, Xealth.
- What companies has Dan Galles invested in?
- Investments tracked here include Lyra, One Medical, Press Ganey.
- Where did Dan Galles go to school?
- Dan Galles studied at Northwestern University - Kellogg School of Management (MBA); University of Pennsylvania (BS, Economics); Regis Jesuit High School.
Same school
Also attended Northwestern University - Kellogg School of Management1,121
+ 1,115 more
Also attended University of Pennsylvania1,404
+ 1,398 more
Also attended Regis Jesuit High School6
Shared employers
Also worked at TailorMed6
Also worked at Kyruus Health15
+ 9 more
Also worked at Xealth6
Also worked at Omada Health26
+ 20 more





















































